Format
Sort by
Items per page

Send to

Choose Destination

Best matches for cystinuria:

Cystinuria: current concepts and future directions. Pereira DJ et al. Clin Nephrol. (2015)

Cystinuria: genetic aspects, mouse models, and a new approach to therapy. Sahota A et al. Urolithiasis. (2019)

Associating mutations causing cystinuria with disease severity with the aim of providing precision medicine. Martell HJ et al. BMC Genomics. (2017)

Search results

Items: 1 to 20 of 1798

1.

The effect of additional drug therapy as metaphylaxis in patients with cystinuria: a systematic review.

Melessen IM, Henderickx MM, Merkx MM, van Etten-Jamaludin FS, Homan van der Heide JJ, Kamphuis GM.

Minerva Urol Nefrol. 2020 Feb 19. doi: 10.23736/S0393-2249.20.03704-2. [Epub ahead of print]

PMID:
32083421
2.

CRISPR/Cas9 engineering of albino cystinuria Type A mice.

Beckermann TM, Welch RC, Williams FM, Mortlock DP, Sha F, Ikizler TA, Woodard LE, Wilson MH.

Genesis. 2020 Feb 20:e23357. doi: 10.1002/dvg.23357. [Epub ahead of print]

PMID:
32078250
3.

Evaluation and medical management of patients with cystine nephrolithiasis: a consensus statement.

Eisner BH, Goldfarb DS, Baum M, Langman CB, Curhan GC, Preminger GM, Lieske J, Pareek G, Thomas K, Zisman A, Papagiannopoulos D, Sur R.

J Endourol. 2020 Feb 17. doi: 10.1089/end.2019.0703. [Epub ahead of print]

PMID:
32066273
4.

Cystinuria in association with cataract.

Singh P, Gupta R, Gupta A.

Indian J Ophthalmol. 2020 Jan;68(1):209. doi: 10.4103/ijo.IJO_1330_19. No abstract available.

5.

Nephrotic syndrome in a patient with cystinuria: Answers.

Aksoy OY, Cakar N.

Pediatr Nephrol. 2019 Dec 13. doi: 10.1007/s00467-019-04440-2. [Epub ahead of print] No abstract available.

PMID:
31834487
6.

Nephrotic syndrome in a patient with cystinuria: Questions.

Aksoy OY, Cakar N.

Pediatr Nephrol. 2019 Dec 13. doi: 10.1007/s00467-019-04439-9. [Epub ahead of print] No abstract available.

PMID:
31834486
7.

Assessment of health-related quality of life in patients with cystinuria on tiopronin therapy.

Modersitzki F, Goldfarb DS, Goldstein RL, Sur RL, Penniston KL.

Urolithiasis. 2019 Dec 13. doi: 10.1007/s00240-019-01174-6. [Epub ahead of print]

PMID:
31834425
8.

Effect of Nanodiamond Surface Chemistry on Adsorption and Release of Tiopronin.

Beltz J, Pfaff A, Abdullahi IM, Cristea A, Mochalin VN, Ercal N.

Diam Relat Mater. 2019 Dec;100. pii: 107590. doi: 10.1016/j.diamond.2019.107590. Epub 2019 Oct 22.

PMID:
31814658
9.

Epidemiology of feline urolithiasis in Mexico (2006-2017).

Mendoza-López CI, Del-Angel-Caraza J, Aké-Chiñas MA, Quijano-Hernández IA, Barbosa-Mireles MA.

JFMS Open Rep. 2019 Nov 24;5(2):2055116919885699. doi: 10.1177/2055116919885699. eCollection 2019 Jul-Dec.

10.

What are the main challenges to the pharmacological management of cystinuria?

Rezaee ME, Rule AD, Pais VM Jr.

Expert Opin Pharmacother. 2020 Feb;21(2):131-133. doi: 10.1080/14656566.2019.1691522. Epub 2019 Nov 14. No abstract available.

PMID:
31724887
11.

The genetic landscape of the human solute carrier (SLC) transporter superfamily.

Schaller L, Lauschke VM.

Hum Genet. 2019 Dec;138(11-12):1359-1377. doi: 10.1007/s00439-019-02081-x. Epub 2019 Nov 2.

12.

Minimal change disease induced by tiopronin: a rare case report and a review of the literature.

Zhong H, Wang L, Gu ZC, Cui M, Liu XY, Pang XY.

Ann Transl Med. 2019 Aug;7(16):398. doi: 10.21037/atm.2019.07.42.

13.

[Inherited kidney stones: A nephrology center experience].

Kaaroud H, Harzallah A, Sayhi M, Bacha M, Khadhar M, Goucha R, Bouzid K, Ayed H, Bouzouita A, Cherif M, Chebil M, Mrad R, Omezzine A, Jallouli M, Gargah T, Ben Hamida F, Ben Abdallah T.

Prog Urol. 2019 Dec;29(16):962-973. doi: 10.1016/j.purol.2019.08.262. Epub 2019 Sep 16. French.

PMID:
31537493
14.

Re: Metabolic Consequences of Cystinuria.

Assimos DG.

J Urol. 2019 Dec;202(6):1091-1093. doi: 10.1097/JU.0000000000000557. Epub 2019 Sep 18. No abstract available.

PMID:
31532293
15.

A novel fluorescent probe for rapidly detection cysteine in cystinuria urine, living cancer/normal cells and BALB/c nude mice.

Dai Y, Zheng Y, Xue T, He F, Ji H, Qi Z.

Spectrochim Acta A Mol Biomol Spectrosc. 2020 Jan 15;225:117490. doi: 10.1016/j.saa.2019.117490. Epub 2019 Aug 27.

PMID:
31505388
16.

[A Case of Long-Term Treatment with Extracorporeal Shock Wave Lithotripsy and Follow-Up for Cystine Calculi by Cystinuria].

Takahashi T, Kanno T, Okada T, Higashi Y, Yamada H.

Hinyokika Kiyo. 2019 Jun;65(6):209-213. doi: 10.14989/ActaUrolJap_65_6_209. Japanese.

PMID:
31501387
17.
18.

Fluorescence Turn-On, Specific Detection of Cystine in Human Blood Plasma and Urine Samples by Nitrogen-Doped Carbon Quantum Dots.

Kalaiyarasan G, Hemlata C, Joseph J.

ACS Omega. 2019 Jan 11;4(1):1007-1014. doi: 10.1021/acsomega.8b03187. eCollection 2019 Jan 31.

19.

Detection of tiopronin in body fluids and pharmaceutical products using red-emissive DNA-stabilized silver nanoclusters as a fluorescent probe.

Zhang P, Jia C, Zhao Y, Luo H, Tan X, Ma X, Wang Y.

Mikrochim Acta. 2019 Aug 8;186(9):609. doi: 10.1007/s00604-019-3730-0.

PMID:
31392427
20.

Cystine Urolithiasis in Early Childhood.

Bhat D, Shankar R, Shenoy RD, Rai S.

Indian J Clin Biochem. 2019 Jul;34(3):361-362. doi: 10.1007/s12291-018-0783-5. Epub 2018 Jul 20.

PMID:
31391730

Supplemental Content

Loading ...
Support Center